Keywords: merck, zocor, effective, diabetics, chd, new, analysis

Merck's Zocor "Effective" In Diabetics With CHD

Article | 09 April 1997

- A new analysis of data from the Scandinavian Simvastatin SurvivalStudy has demonstrated that treating people suffering from both diabetes and ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Merck

Merck KGaA

Go to company listing

Related Drugs

Simvastatin

Zocor

Go to drug listing